Immutep (IMMP) Other Non Operating Income (2015 - 2024)

Immutep's (IMMP) quarterly Other Non Operating Income came in at $74771.6 in Q2 2024, down 78.38% on a QoQ basis from $345848.4 in Q2 2019.

Immutep (IMMP) Other Non Operating Income (2015 - 2024) Analysis & Trends

Immutep (IMMP) has 5 years of Other Non Operating Income data on file, last reported at $74771.6 in Q2 2024.

Quarterly Other Non Operating Income changed N/A year-over-year to $74771.6 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $700582.9 (changed N/A YoY) and the FY2024 annual result came in at $74771.6, changed N/A from the prior year.
Other Non Operating Income fell to $74771.6 in Q2 2024, from $345848.4 in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $74771.6 in Q2 2024 to a low of $74771.6 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Immutep	56.46 Mn	-8.63 Mn	-

Download Data